Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP8148.RAcMtbDmKP_Ge9_-Y2Vrd-d8Al0BDwQ_oheXYsPSARzcE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP8148.RAcMtbDmKP_Ge9_-Y2Vrd-d8Al0BDwQ_oheXYsPSARzcE130_assertion type Assertion NP8148.RAcMtbDmKP_Ge9_-Y2Vrd-d8Al0BDwQ_oheXYsPSARzcE130_head.
- NP8148.RAcMtbDmKP_Ge9_-Y2Vrd-d8Al0BDwQ_oheXYsPSARzcE130_assertion description "[At this dose, lethality was reduced to 30% (p < 0.001) and seizures were reduced to 40% (p < 0.001) by administration of 27.4 mg/kg of human plasma cholinesterase.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP8148.RAcMtbDmKP_Ge9_-Y2Vrd-d8Al0BDwQ_oheXYsPSARzcE130_provenance.
- NP8148.RAcMtbDmKP_Ge9_-Y2Vrd-d8Al0BDwQ_oheXYsPSARzcE130_assertion evidence source_evidence_curated NP8148.RAcMtbDmKP_Ge9_-Y2Vrd-d8Al0BDwQ_oheXYsPSARzcE130_provenance.
- NP8148.RAcMtbDmKP_Ge9_-Y2Vrd-d8Al0BDwQ_oheXYsPSARzcE130_assertion SIO_000772 8667461 NP8148.RAcMtbDmKP_Ge9_-Y2Vrd-d8Al0BDwQ_oheXYsPSARzcE130_provenance.
- NP8148.RAcMtbDmKP_Ge9_-Y2Vrd-d8Al0BDwQ_oheXYsPSARzcE130_assertion wasDerivedFrom ctd_human-20150221 NP8148.RAcMtbDmKP_Ge9_-Y2Vrd-d8Al0BDwQ_oheXYsPSARzcE130_provenance.
- NP8148.RAcMtbDmKP_Ge9_-Y2Vrd-d8Al0BDwQ_oheXYsPSARzcE130_assertion wasGeneratedBy ECO_0000218 NP8148.RAcMtbDmKP_Ge9_-Y2Vrd-d8Al0BDwQ_oheXYsPSARzcE130_provenance.